Osteopontin, a multi-faceted molecule

被引:35
|
作者
Chabas, D
机构
[1] Univ Paris 06, INSERM, U546, F-75013 Paris, France
[2] UPMC, Fed Maladies Syst Nerveux, Hop La Pitie Salpetriere, F-75013 Paris, France
来源
M S-MEDECINE SCIENCES | 2005年 / 21卷 / 10期
关键词
D O I
10.1051/medsci/20052110832
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Osteopontin (OPN) was initially isolated from bovine bone cortex, as a complex syalilated phospho-glyco-protein of around 60 kDa, with many postronslational modifications. It has been long considered a structural bone protein linking bone cells to the bone extracellular matrix (osteo : bone, pontin : bridge). It has been cloned for the first time in 1986. Since then, it was established that it is part of a protein family called SIBLINGS, which genes share common expression in bone and tooth, and encode among others a RGD motif. OPN is an intracellular as well as secreted protein, which binds to multiple organic or mineral ligands, like the integrin receptor alpha V beta 3, CD44, factor H and hydroxyapatite, depending on its final configuration (phosphorylation state). Pleiotropic functions of osteopontin have been demonstrated, and the osteopontin knock out phenotype in mice gave some new insight on the implication of the molecule in vivo. Osteopontin inhibits mineralization in bone and urine. Besides, it is a strong chemoattractive and proinflammatory molecule, implicated in tumors, like breast or prostate cancers, and in the defense against various infectious agents like tuberculosis, listeria or herpes. More recently, its key implication in TH1 mediated autoimmune diseases like multiple sclerosis and its animal model experimental autoimmune encephalomyelitis has been demonstrated. Osteopontin is a valuable therapeutic target in the animal model, and a biological tool correlating with clinical disease activity in humans. Structural, functional and pathological aspects of osteopontin are reviewed, as well as the osteopontin deficient phenotype in mouse.
引用
收藏
页码:832 / 838
页数:7
相关论文
共 50 条
  • [1] Clozapine: The Multi-Faceted Molecule In Psychiatry
    Chakrabarti, Sarmishtha
    Bhattacharjee, Subir
    Sarkhel, Sujit
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2017, 59 (06) : S165 - S165
  • [2] Multi-faceted small molecule for Alzheimer's disease
    Park, Min Hee
    Jin, Hee Kyung
    Bae, Jae-sung
    [J]. NEURAL REGENERATION RESEARCH, 2023, 18 (10) : 2198 - 2199
  • [3] Multi-faceted small molecule for Alzheimer's disease
    Min Hee Park
    Hee Kyung Jin
    Jae-sung Bae
    [J]. Neural Regeneration Research, 2023, (10) : 2198 - 2199
  • [4] HDL A molecule with a multi-faceted role in coronary artery disease
    Arora, Sarika
    Patra, Surajeet K.
    Saini, Reetika
    [J]. CLINICA CHIMICA ACTA, 2016, 452 : 66 - 81
  • [6] FOR A MULTI-FACETED EVALUATION
    LALONDE, P
    [J]. CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL, 1972, 17 (03): : 201 - 203
  • [7] A Multi-Faceted Approach
    Moran, Sarah
    [J]. EDUCATIONAL LEADERSHIP, 2019, 77 (02) : 93 - 93
  • [8] Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma
    Qiu Yushi
    Li, Zhimin
    Von Roemeling, Christina A.
    Doeppler, Heike
    Marlow, Laura A.
    Kim, Betty Y. S.
    Radisky, Derek C.
    Storz, Peter
    Copland, John A.
    Tun, Han W.
    [J]. ONCOTARGET, 2016, 7 (22) : 32156 - 32171
  • [10] Psychologists and Neoliberal School Reforms: Multi-Faceted Problems Calling for Multi-Faceted Interventions
    Thomas Boll
    [J]. Integrative Psychological and Behavioral Science, 2018, 52 : 425 - 437